Bank of New York Mellon’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,206
Closed -$123K 4140
2025
Q1
$123K Sell
23,206
-1
-0% -$5 ﹤0.01% 3953
2024
Q4
$274K Sell
23,207
-1,069
-4% -$12.6K ﹤0.01% 3804
2024
Q3
$501K Sell
24,276
-5,960
-20% -$123K ﹤0.01% 3509
2024
Q2
$1.37M Buy
+30,236
New +$1.37M ﹤0.01% 3006
2023
Q1
Sell
-1,069
Closed -$3.54K 4391
2022
Q4
$3.54K Sell
1,069
-74
-6% -$245 ﹤0.01% 4455
2022
Q3
$5K Hold
1,143
﹤0.01% 4532
2022
Q2
$9K Hold
1,143
﹤0.01% 4553
2022
Q1
$18K Hold
1,143
﹤0.01% 4619
2021
Q4
$21K Hold
1,143
﹤0.01% 4580
2021
Q3
$35K Sell
1,143
-5,431
-83% -$166K ﹤0.01% 4469
2021
Q2
$361K Sell
6,574
-2,330
-26% -$128K ﹤0.01% 3908
2021
Q1
$527K Buy
8,904
+1,357
+18% +$80.3K ﹤0.01% 3656
2020
Q4
$282K Sell
7,547
-1,546
-17% -$57.8K ﹤0.01% 3852
2020
Q3
$492K Buy
9,093
+72
+0.8% +$3.9K ﹤0.01% 3497
2020
Q2
$2.27M Buy
9,021
+1,757
+24% +$442K ﹤0.01% 2606
2020
Q1
$1.14M Buy
7,264
+624
+9% +$98.2K ﹤0.01% 2879
2019
Q4
$1.09M Buy
6,640
+134
+2% +$22K ﹤0.01% 3200
2019
Q3
$951K Sell
6,506
-498
-7% -$72.8K ﹤0.01% 3203
2019
Q2
$1.46M Buy
7,004
+137
+2% +$28.5K ﹤0.01% 2990
2019
Q1
$1.43M Buy
6,867
+388
+6% +$80.9K ﹤0.01% 2957
2018
Q4
$1.14M Buy
6,479
+543
+9% +$95.1K ﹤0.01% 3031
2018
Q3
$1.34M Sell
5,936
-321
-5% -$72.7K ﹤0.01% 3079
2018
Q2
$948K Sell
6,257
-68
-1% -$10.3K ﹤0.01% 3272
2018
Q1
$1.16M Buy
6,325
+6
+0.1% +$1.1K ﹤0.01% 3131
2017
Q4
$1.35M Buy
6,319
+1,314
+26% +$280K ﹤0.01% 3066
2017
Q3
$1.07M Buy
5,005
+445
+10% +$95.4K ﹤0.01% 3178
2017
Q2
$862K Buy
4,560
+3,857
+549% +$729K ﹤0.01% 3334
2017
Q1
$174K Buy
703
+50
+8% +$12.4K ﹤0.01% 3908
2016
Q4
$166K Sell
653
-110
-14% -$28K ﹤0.01% 3939
2016
Q3
$155K Buy
+763
New +$155K ﹤0.01% 3947